These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31358139)

  • 1. Prostaglandin analogue drops for the treatment of soft tissue expansion and exophthalmos in patients with inactive thyroid eye disease.
    Eiger-Moscovich M; Stiebel-Kalish H; Yassur I; Barash D; Gaton D; Avisar I
    Can J Ophthalmol; 2019 Aug; 54(4):426-430. PubMed ID: 31358139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospects of the use of prostaglandin analogues in the treatment of patients with thyroid eye disease].
    Melovatskiy PD; Krylova EI; Grusha YO
    Vestn Oftalmol; 2022; 138(5. Vyp. 2):285-288. PubMed ID: 36287169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin F2-Alpha Eye Drops (Bimatoprost) in Graves' Orbitopathy: A Randomized Controlled Double-Masked Crossover Trial (BIMA Trial).
    Draman MS; Morris DS; Evans S; Haridas A; Pell J; Greenwood R; Foy C; Taylor P; Pooprasert P; Muller I; Zhang L; Lane C; Okosieme O; Ludgate M; Dayan C
    Thyroid; 2019 Apr; 29(4):563-572. PubMed ID: 30880626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periorbital changes associated with prostaglandin analogs in Korean patients.
    Kim HW; Choi YJ; Lee KW; Lee MJ
    BMC Ophthalmol; 2017 Jul; 17(1):126. PubMed ID: 28716077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral Prostaglandin-Associated Periorbitopathy: A Syndrome Involving Upper Eyelid Retraction Distinguishable From the Aging Sunken Eyelid.
    Rabinowitz MP; Katz LJ; Moster MR; Myers JS; Pro MJ; Spaeth GL; Sharma P; Stefanyszyn MA
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):373-8. PubMed ID: 25393907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs.
    Inoue K; Shiokawa M; Wakakura M; Tomita G
    J Glaucoma; 2013; 22(8):626-31. PubMed ID: 22936280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost.
    Kucukevcilioglu M; Bayer A; Uysal Y; Altinsoy HI
    Clin Exp Ophthalmol; 2014 Mar; 42(2):126-31. PubMed ID: 23844550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in eyelid parameters after orbital decompression in thyroid-associated orbitopathy.
    Park HH; Chun YS; Moon NJ; Kim JT; Park SJ; Lee JK
    Eye (Lond); 2018 Jun; 32(6):1036-1041. PubMed ID: 29391576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Prostaglandin Analogue Bimatoprost on Thyroid-Associated Orbitopathy.
    Choi CJ; Tao W; Doddapaneni R; Acosta-Torres Z; Blessing NW; Lee BW; Pelaez D; Wester ST
    Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5912-5923. PubMed ID: 30551199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with bimatoprost for exophthalmos in patients with inactive thyroid-associated ophthalmopathy.
    Higashiyama T; Ohji M
    Clin Ophthalmol; 2018; 12():2415-2421. PubMed ID: 30568419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bimatoprost-induced chemical blepharoplasty.
    Sarnoff DS; Gotkin RH
    J Drugs Dermatol; 2015 May; 14(5):472-7. PubMed ID: 25942665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multi-wall orbital decompression for disfiguring proptosis in patients with mild or moderate thyroid eye disease].
    Wang Y; Yang N; Li YY; Xiao LH
    Zhonghua Yan Ke Za Zhi; 2017 Feb; 53(2):128-135. PubMed ID: 28260364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues.
    Seal JR; Robinson MR; Burke J; Bejanian M; Coote M; Attar M
    J Ocul Pharmacol Ther; 2019; 35(1):50-57. PubMed ID: 30335560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study.
    Bourne RRA; Kaarniranta K; Lorenz K; Traverso CE; Vuorinen J; Ropo A
    BMJ Open; 2019 Apr; 9(4):e024129. PubMed ID: 30944129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy.
    Choi SW; Lee JY; Lew H
    Korean J Ophthalmol; 2016 Feb; 30(1):1-9. PubMed ID: 26865797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Prostaglandin Analogues on the Ciliary Zonular Fibers of the Rabbit Crystalline Lens.
    Hwang HB; Kim SY
    Curr Eye Res; 2018 Nov; 43(11):1357-1361. PubMed ID: 30015523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension.
    Natt NK; Gupta A; Singh G; Singh T
    Indian J Ophthalmol; 2014 Dec; 62(12):1136-40. PubMed ID: 25579357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid eye disease: a Southeast Asian experience.
    Lim NC; Sundar G; Amrith S; Lee KO
    Br J Ophthalmol; 2015 Apr; 99(4):512-8. PubMed ID: 25361748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periorbital changes associated with topical bimatoprost.
    Filippopoulos T; Paula JS; Torun N; Hatton MP; Pasquale LR; Grosskreutz CL
    Ophthalmic Plast Reconstr Surg; 2008; 24(4):302-7. PubMed ID: 18645437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient persistency with ocular prostaglandin therapy: a population-based, retrospective study.
    Reardon G; Schwartz GF; Mozaffari E
    Clin Ther; 2003 Apr; 25(4):1172-85. PubMed ID: 12809964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.